Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001934760 | SCV002136144 | pathogenic | Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form | 2022-04-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln259*) in the CLCN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLCN1 are known to be pathogenic (PMID: 17932099, 22094069, 23739125). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CLCN1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Department Of Human Genetics, |
RCV004527434 | SCV005038738 | likely pathogenic | Congenital myotonia, autosomal recessive form | criteria provided, single submitter | research | The c.775C>T (p.(Gln259*)) variant was found in a homozygous state in 1 Slovak patient with Myotonia congenita. It leads to a premature stop codon and has not been reported in the public part of the HGMD or gnomAD Exomes databases. No other Pathogenic or Likely pathogenic variants were found in this individual. |